Lineage Cell Therapeutics has begun the DOSED study to assess the utility and safety of the Manual Inject Parenchymal Spinal Delivery System (MI PSD System) designed for direct delivery of ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological ...
- Overall safety profile of OPC1 to date is excellent for Year 2 follow-ups available to date (21 patients) Magnetic resonance imaging (MRI) scans at 24 months post-injection of OPC1 have shown no ...
CARLSBAD, Calif.--(BUSINESS WIRE)-- Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
OPC1 has been tested in two clinical trials to date; a five patient Phase 1 clinical safety trial in acute thoracic SCI, where all subjects have been followed for at least 10 years; as well as a 25 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it has entered ...
CARLSBAD, Calif.--(BUSINESS WIRE)--$LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...
Results from an ongoing treatment for spinal cord injury research study were announced by the biotechnology company that manufactures AST-OPC1. A new therapy to treat spinal cord injuries in people ...
After receiving a stem cell injection into his spine, Kris Boesen, who was paralyzed from his neck to his toes after a car accident, is regaining movement in his extremities and hope for increased ...
FREMONT, Calif., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Washington ...
Improvements Implemented in OPC1 Production Process Patent Position Strengthened to Protect the Processes, Product, and Methods of Use Company is Evaluating Novel Delivery Devices to Enhance and Ease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results